{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:29:54Z","timestamp":1785814194133,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-106-2911-I-020-501"],"award-info":[{"award-number":["MOST-106-2911-I-020-501"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-107-2313-B-020-011-MY3"],"award-info":[{"award-number":["MOST-107-2313-B-020-011-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/P025080\/1"],"award-info":[{"award-number":["BB\/P025080\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Both current live, attenuated, and killed virus vaccines for bovine viral diarrhea virus (BVDV) have their limitations. Here, we report the development of a BVDV subunit vaccine by (i) the expression of a secreted form of a recombinant E2 glycoprotein using BHK21 cells and (ii) determination of the immune responses in mice. The E2 glycoprotein was modified by deletion of the C-terminal transmembrane anchor domain and fusion to a V5 epitope tag. This allowed detection using anti-V5 monoclonal antibodies together with simple purification of the expressed, secreted, form of E2 from the cell media. Furthermore, we genetically fused green fluorescent protein (GFP) linked to E2 via a <jats:italic>Thosea asigna<\/jats:italic> virus 2A (T2A) ribosome skipping sequence thereby creating a self-processing polyprotein [GFP-T2A-BVDV-E2<jats:sup>trunk<\/jats:sup>-V5], producing discrete [GFP-T2A] and [E2<jats:sup>trunk<\/jats:sup>-V5] translation products: GFP fluorescence acts, therefore, as a surrogate marker of E2 expression, BALB\/c mice were inoculated with [E2<jats:sup>trunk<\/jats:sup>-V5] purified from cell media and both humoral and cellular immune responses were observed. Our antigen expression system provides, therefore, both (i) a simple antigen purification protocol together with (ii) a feasible strategy for further, large-scale, production of vaccines.<\/jats:p>","DOI":"10.1038\/s41598-022-26766-y","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T13:04:53Z","timestamp":1673010293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunogenicity of a secreted, C-terminally truncated, form of bovine viral diarrhea virus E2 glycoprotein as a potential candidate in subunit vaccine development"],"prefix":"10.1038","volume":"13","author":[{"given":"Yi Ting","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry A.","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing Chieh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"26766_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biologicals.2012.07.009","volume":"41","author":"RW Fulton","year":"2013","unstructured":"Fulton, R. W. Host response to bovine viral diarrhea virus and interactions with infectious agents in the feedlot and breeding herd. Biologicals 41, 31\u201338 (2013).","journal-title":"Biologicals"},{"key":"26766_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1939-1676.1989.tb00327.x","volume":"3","author":"WC Rebhun","year":"1989","unstructured":"Rebhun, W. C. et al. Thrombocytopenia associated with acute bovine virus diarrhea infection in cattle. J. Vet. Intern. Med. 3, 42\u201346 (1989).","journal-title":"J. Vet. Intern. Med."},{"key":"26766_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1045-1056(03)00029-0","volume":"31","author":"KV Brock","year":"2003","unstructured":"Brock, K. V. The persistence of bovine viral diarrhea virus. Biologicals 31, 133\u2013135 (2003).","journal-title":"Biologicals"},{"key":"26766_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0378-1135(98)00262-4","volume":"64","author":"H Houe","year":"1999","unstructured":"Houe, H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet. Microbiol. 64, 89\u2013107 (1999).","journal-title":"Vet. Microbiol."},{"key":"26766_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tvjl.2017.01.005","volume":"220","author":"V Richter","year":"2017","unstructured":"Richter, V. et al. A systematic worldwide review of the direct monetary losses in cattle due to bovine viral diarrhoea virus infection. Vet. J. 220, 80\u201387 (2017).","journal-title":"Vet. J."},{"key":"26766_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-animal-022513-114209","volume":"2","author":"M Schweizer","year":"2014","unstructured":"Schweizer, M. & Peterhans, E. Pestiviruses. Annu. Rev. Anim. Biosci. 2, 141\u2013163 (2014).","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"26766_CR7","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3201\/eid1708.101447","volume":"17","author":"N Decaro","year":"2011","unstructured":"Decaro, N. et al. Atypical pestivirus and severe respiratory disease in calves. Europe. Emerg. Infect. Dis. 17, 1549\u20131552 (2011).","journal-title":"Europe. Emerg. Infect. Dis."},{"key":"26766_CR8","first-page":"568","volume":"186","author":"AW McClurkin","year":"1985","unstructured":"McClurkin, A. W., Bolin, S. R. & Coria, M. F. Isolation of cytopathic and noncytopathic bovine viral diarrhea virus from the spleen of cattle acutely and chronically affected with bovine viral diarrhea. J. Am. Vet. Med. Assoc. 186, 568\u2013569 (1985).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"26766_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0749-0720(15)30462-X","volume":"11","author":"V Moennig","year":"1995","unstructured":"Moennig, V. & Liess, B. Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet. Clin. N. Am. Food Anim. Pract. 11, 477\u2013487 (1995).","journal-title":"Vet. Clin. N. Am. Food Anim. Pract."},{"key":"26766_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/v9060128","volume":"9","author":"K Ye\u015filba\u011f","year":"2017","unstructured":"Ye\u015filba\u011f, K., Alpay, G. & Becher, P. Variability and global distribution of subgenotypes of bovine viral diarrhea virus. Viruses 9, 128 (2017).","journal-title":"Viruses"},{"key":"26766_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/pathogens7010029","volume":"7","author":"V Moennig","year":"2018","unstructured":"Moennig, V. & Becher, P. Control of bovine viral diarrhea. Pathogens 7, 29 (2018).","journal-title":"Pathogens"},{"key":"26766_CR12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.theriogenology.2010.01.017","volume":"73","author":"SP Rodning","year":"2010","unstructured":"Rodning, S. P. et al. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus. Theriogenology 73, 1154\u20131163 (2010).","journal-title":"Theriogenology"},{"key":"26766_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/vaccines8040577","volume":"8","author":"S Koethe","year":"2020","unstructured":"Koethe, S. et al. A synthetic modified live chimeric marker vaccine against BVDV-1 and BVDV-2. Vaccines 8, 577\u2013599 (2020).","journal-title":"Vaccines"},{"key":"26766_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/vaccines9030259","volume":"9","author":"MD Klimowicz-Bodys","year":"2021","unstructured":"Klimowicz-Bodys, M. D. et al. Antibody response to a live-modified virus vaccine against bovine viral diarrhoea in dairy cattle in a field trial. Vaccines 9, 259\u2013266 (2021).","journal-title":"Vaccines"},{"key":"26766_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2021.665128","volume":"8","author":"AAG Al-Kubati","year":"2021","unstructured":"Al-Kubati, A. A. G., Hussen, J., Kandeel, M., Al-Mubarak, A. I. A. & Hemida, M. G. Recent advances on the bovine viral diarrhea virus molecular pathogenesis, immune response, and vaccines development. Front. Vet. Sci. 8, 1\u201315 (2021).","journal-title":"Front. Vet. Sci."},{"key":"26766_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1128\/CVI.00071-06","volume":"13","author":"G Donofrio","year":"2006","unstructured":"Donofrio, G., Bottarelli, E., Sandro, C. & Flammini, C. F. Expression of bovine viral diarrhea virus glycoprotein E2 as a soluble secreted form in a mammalian cell line. Clin. Vaccine Immunol. 13, 698\u2013701 (2006).","journal-title":"Clin. Vaccine Immunol."},{"key":"26766_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12917-017-1305-z","volume":"13","author":"C Nogarol","year":"2017","unstructured":"Nogarol, C. et al. Pestivirus infection in cattle dairy farms: E2 glycoprotein ELISA reveals the presence of bovine viral diarrhea virus type 2 in northwestern Italy. BMC Vet. Res. 13, 377\u2013385 (2017).","journal-title":"BMC Vet. Res."},{"key":"26766_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1398-9219.2004.00205.x","volume":"5","author":"P de Felipe","year":"2004","unstructured":"de Felipe, P. & Ryan, M. D. Targeting of proteins derived from self-processing polyproteins containing multiple signal sequences. Traffic 5, 616\u2013626 (2004).","journal-title":"Traffic"},{"key":"26766_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tibtech.2005.12.006","volume":"24","author":"P de Felipe","year":"2006","unstructured":"de Felipe, P. et al. E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol. 24, 68\u201375 (2006).","journal-title":"Trends Biotechnol."},{"key":"26766_CR20","first-page":"310","volume":"7","author":"R Gupta","year":"2002","unstructured":"Gupta, R. & Brunak, S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput. 7, 310\u2013322 (2002).","journal-title":"Pac. Symp. Biocomput."},{"key":"26766_CR21","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.vaccine.2020.03.058","volume":"38","author":"RW Fulton","year":"2020","unstructured":"Fulton, R. W., Cook, B. J., Payton, M. E., Burge, L. J. & Step, D. L. Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c. Vaccine 38, 4032\u20134037 (2020).","journal-title":"Vaccine"},{"key":"26766_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.vetimm.2017.03.003","volume":"187","author":"R Platt","year":"2017","unstructured":"Platt, R., Kesl, L., Guidarini, C., Wang, C. & Roth, J. A. Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela\u00ae live double deleted BVDV vaccine or to a field BVDV strain. Vet. Immunol. Immunopathol. 187, 20\u201327 (2017).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"26766_CR23","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1128\/JVI.02372-06","volume":"81","author":"G Meyers","year":"2007","unstructured":"Meyers, G. et al. Bovine viral diarrhea virus: prevention of persistent fetal infection by a combination of two mutations affecting Erns RNase and Npro protease. J. Virol. 81, 3327\u20133338 (2007).","journal-title":"J. Virol."},{"key":"26766_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/v10050274","volume":"10","author":"K Wernike","year":"2018","unstructured":"Wernike, K. et al. The occurrence of a commercial Npro and Erns double mutant BVDV-1 live-vaccine strain in newborn calves. Viruses 10, 274\u2013281 (2018).","journal-title":"Viruses"},{"key":"26766_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/104063879100300302","volume":"3","author":"SR Bolin","year":"1991","unstructured":"Bolin, S. R., Matthews, P. J. & Ridpath, J. F. Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus. J. Vet. Diagn. Invest. 3, 199\u2013203 (1991).","journal-title":"J. Vet. Diagn. Invest."},{"key":"26766_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1045-1056(03)00058-7","volume":"31","author":"B Makoschey","year":"2003","unstructured":"Makoschey, B., van Gelder, P. T., Keijsers, V. & Goovaerts, D. Bovine viral diarrhoea virus antigen in foetal calf serum batches and consequences of such contamination for vaccine production. Biologicals 31, 203\u2013208 (2003).","journal-title":"Biologicals"},{"key":"26766_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.theriogenology.2014.09.028","volume":"83","author":"BW Newcomer","year":"2015","unstructured":"Newcomer, B. W., Walz, P. H., Givens, M. D. & Wilson, A. E. Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: a meta-analysis. Theriogenology 83, 360\u2013365 (2015).","journal-title":"Theriogenology"},{"key":"26766_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.vetimm.2007.11.009","volume":"122","author":"R Platt","year":"2008","unstructured":"Platt, R., Coutu, C., Meinert, T. & Roth, J. A. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle. Vet. Immunol. Immunopathol. 122, 8\u201315 (2008).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"26766_CR29","first-page":"E1","volume":"10","author":"ET Stevens","year":"2009","unstructured":"Stevens, E. T. et al. The induction of a cell-mediated immune response to bovine viral diarrhea virus with an adjuvanted inactivated vaccine. Vet. Ther. 10, E1\u2013E8 (2009).","journal-title":"Vet. Ther."},{"key":"26766_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/vaccines8030374","volume":"8","author":"E Sozzi","year":"2020","unstructured":"Sozzi, E. et al. Cross-reactivity antibody response after vaccination with modified live and killed bovine viral diarrhoea virus (BVD) vaccines. Vaccines 8, 374\u2013383 (2020).","journal-title":"Vaccines"},{"key":"26766_CR31","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1016\/j.vaccine.2018.04.005","volume":"36","author":"PH Walz","year":"2018","unstructured":"Walz, P. H. et al. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2. Vaccine 36, 3853\u20133860 (2018).","journal-title":"Vaccine"},{"key":"26766_CR32","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/jam.15044","volume":"131","author":"YT Lo","year":"2021","unstructured":"Lo, Y. T. et al. Expression and immunogenicity of secreted forms of bovine ephemeral fever virus glycoproteins applied to subunit vaccine development. J. Appl. Microbiol. 131, 1123\u20131135 (2021).","journal-title":"J. Appl. Microbiol."},{"key":"26766_CR33","doi-asserted-by":"publisher","first-page":"107552","DOI":"10.1016\/j.biotechadv.2020.107552","volume":"43","author":"R O'Flaherty","year":"2020","unstructured":"O\u2019Flaherty, R. et al. Mammalian cell culture for production of recombinant protein: a review of the critical steps in their biomanufacturing. Biotechnol. Adv. 43, 107552\u2013107568 (2020).","journal-title":"Biotechnol. Adv."},{"key":"26766_CR34","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.4049\/jimmunol.1201789","volume":"189","author":"Q Chen","year":"2012","unstructured":"Chen, Q., He, F., Kwang, J., Chan, J. K. & Chen, J. GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J. Immunol. 189, 5223\u20135229 (2012).","journal-title":"J. Immunol."},{"key":"26766_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1556\/avet.59.2011.1.13","volume":"59","author":"M Balenovi\u0107","year":"2011","unstructured":"Balenovi\u0107, M., Savi\u0107, V., Ekert Kabalin, A., Jurinovi\u0107, L. & Ragland, W. L. Abundance of IFN-\u03b1 and IFN-\u03b3 gene transcripts and absence of IL-2 transcripts in the blood of chickens vaccinated with live or inactivated NDV. Acta Vet. Hung. 59, 141\u2013148 (2011).","journal-title":"Acta Vet. Hung."},{"key":"26766_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb01010.x","volume":"159","author":"PC Doherty","year":"1997","unstructured":"Doherty, P. C. et al. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159, 105\u2013117 (1997).","journal-title":"Immunol. Rev."},{"key":"26766_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/fvl.13.82","volume":"8","author":"GA Luke","year":"2013","unstructured":"Luke, G. A. & Ryan, M. D. The protein coexpression problem in biotechnology and biomedicine: virus 2A and 2A-like sequences provide a solution. Future Virol. 8, 1\u201313 (2013).","journal-title":"Future Virol."},{"key":"26766_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1472-6750-13-67","volume":"13","author":"E Minskaia","year":"2013","unstructured":"Minskaia, E., Nicholson, J. & Ryan, M. D. Optimisation of the foot-and-mouth disease virus 2A coexpression system for biomedical applications. BMC Biotechnol. 13, 67\u201377 (2013).","journal-title":"BMC Biotechnol."},{"key":"26766_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12917-018-1520-2","volume":"14","author":"YC Chung","year":"2018","unstructured":"Chung, Y. C. et al. Recombinant E2 protein enhances protective efficacy of inactivated bovine viral diarrhea virus 2 vaccine in a goat model. BMC Vet. Res. 14, 194\u2013202 (2018).","journal-title":"BMC Vet. Res."},{"key":"26766_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"26766_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.17221\/1882-VETMED","volume":"52","author":"E Kosinova","year":"2007","unstructured":"Kosinova, E., Psikal, I., Robesova, B. & Kovarcik, K. Real-time PCR for quantitation of bovine viral diarrhea virus RNA using SYBR green I fluorimetry. Vet. Med. 52, 253\u2013261 (2007).","journal-title":"Vet. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26766-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T20:04:35Z","timestamp":1673121875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26766-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["26766"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26766-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}